Lexeo Therapeutics (LXEO) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the CEO, with board members, management, and external advisors present.

• Agenda and rules of conduct posted on the virtual meeting website; stockholders instructed to follow them.

• The meeting would address and vote on two proposals, with a Q&A session to follow after adjournment.

Shareholder proposals

• Proposal 1: Election of three Class III directors for a three-year term expiring in 2029.

• Proposal 2: Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

Overview of voting outcomes

• Quorum confirmed with sufficient shares present in person or by proxy.

• Both proposals passed: directors elected and KPMG LLP ratified as auditor.

• Final voting results to be filed on Form 8-K within four business days.